D. E. Shaw & Co., Inc. Concert Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $494,100 - $664,872	113,848 New	113,848 $664,000
Q2 2022 Aug 15, 2022	SELL	$2.8 - $6.36 $18,608 - $42,268	-6,646 Reduced 20.42%	25,901 $109,000
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $34,867 - $50,321	-12,772 Reduced 28.18%	32,547 $110,000
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $49,216 - $77,209	18,296 Added 67.71%	45,319 $143,000
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $14,911 - $19,521	-4,704 Reduced 14.83%	27,023 $88,000
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $139,874 - $194,414	-37,102 Reduced 53.9%	31,727 $134,000
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $52,274 - $140,580	10,756 Added 18.52%	68,829 $344,000
Q4 2020 Feb 16, 2021	BUY	$9.48 - $12.84 $18,997 - $25,731	2,004 Added 3.57%	58,073 $734,000
Q3 2020 Nov 16, 2020	BUY	$8.67 - $10.82 $203,554 - $254,031	23,478 Added 72.04%	56,069 $551,000
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $36,340 - $53,671	4,659 Added 16.68%	32,591 $324,000
Q1 2020 May 15, 2020	SELL	$5.98 - $13.09 $74,744 - $163,611	-12,499 Reduced 30.91%	27,932 $247,000
Q4 2019 Feb 14, 2020	BUY	$5.71 - $9.22 $2,021 - $3,263	354 Added 0.88%	40,431 $373,000
Q3 2019 Nov 14, 2019	SELL	$5.88 - $12.35 $64,044 - $134,516	-10,892 Reduced 21.37%	40,077 $236,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $73,745 - $102,493	7,812 Added 18.1%	50,969 $612,000
Q1 2019 May 15, 2019	SELL	$12.07 - $17.54 $11,044 - $16,049	-915 Reduced 2.08%	43,157 $521,000
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $253,901 - $364,940	-22,569 Reduced 33.87%	44,072 $553,000
Q3 2018 Nov 14, 2018	BUY	$12.82 - $17.88 $97,149 - $135,494	7,578 Added 12.83%	66,641 $989,000
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $205,258 - $264,165	12,196 Added 26.02%	59,063 $994,000
Q1 2018 May 15, 2018	SELL	$19.24 - $28.03 $1.09 Million - $1.59 Million	-56,550 Reduced 54.68%	46,867 $1.07 Million
Q4 2017 Feb 14, 2018	SELL	$13.96 - $29.05 $2.77 Million - $5.76 Million	-198,419 Reduced 65.74%	103,417 $2.68 Million
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $4.2 Million - $4.62 Million	301,836	301,836 $4.45 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account